Artículos de interés
 
       
       
    Un servicio de APaldía
(http://www.apaldia.com)
 
       
       
    Artículos de interés publicados la semana del 26/07/2010 al 01/08/2010

PREVENCIÓN CARDIOVASCULAR
Coppell KJ, Kataoka M, Williams SM, Chisholm AW, Vorgers SM, Mann JI. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimised drug treatment—Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomised controlled trial. BMJ 2010; 341: 3337-. R TC PDF
Clifton P. Nutrition in people with poorly controlled type 2 diabetes. BMJ 2010; 341: 3393-. R TC PDF
Rea TD, Fahrenbruch C, Culley L, Donohoe RT, Hambly C, Innes J et al. CPR with Chest Compression Alone or with Rescue Breathing. N Engl J Med 2010; 363: 423-433. R TC PDF
Svensson L, Bohm K, Castrèn M, Pettersson H, Engerström L, Herlitz J et al. Compression-Only CPR or Standard CPR in Out-of-Hospital Cardiac Arrest. N Engl J Med 2010; 363: 434-442. R TC PDF
The HEALTHY Study Group. A School-Based Intervention for Diabetes Risk Reduction. N Engl J Med 2010; 363: 443-453. R TC PDF
Weisfeldt ML. In CPR, Less May Be Better. N Engl J Med 2010; 363: 481-483. R TC PDF
McCance DR, Holmes VA, Maresh MJA, Patterson ChC, Walker JD, Pearson DWM et al for the Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet 2010; 376: 259-266. R TC PDF
Sibai BM. Vitamin C and E to prevent pre-eclampsia in diabetic women. Lancet 2010; 376: 214-216. R TC PDF
Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley Ch, Worrall Ch et al. Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone. JAMA 2010; 304: 411-418. R TC PDF
Juurlink DN. Rosiglitazone and the Case for Safety Over Certainty. JAMA 2010; 304: 469-471. R TC PDF
Lang S, Mary-Krause M, Cotte L. Gilquin J, Partisani M, Simon A et al. Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected Patients: A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4. Arch Intern Med 2010; 170: 1228-1238. R TC PDF
Nissen SE, Wolski K. Rosiglitazone Revisited: An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality. Arch Intern Med 2010; 170: 1191-1201. R TC PDF
Varma N, Epstein AE, Irimpen A, Schweikert R, Love C for the TRUST Investigators. Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial. Circulation 2010; 122: 325-332. R TC PDF
Gottlieb DJ, Yenokyan G, Newman AB, O´Connor GT, Punjabi NM, Quan SF et al. Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure: The Sleep Heart Health Study. Circulation 2010; 122: 352-360. R TC PDF
Gerdes AM, Iervasi G. Thyroid Replacement Therapy and Heart Failure. Circulation 2010; 122: 385-393. R TC PDF
Wiviott SD, Elliott M. Antman EM, Braunwald E. Prasugrel. Circulation 2010; 122: 394-403. R TC PDF
Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH et al on behalf of the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing. Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults: A Scientific Statement From the American Heart Association. Circulation 2010; 122: 406-441. R TC PDF
EDUCACIÓN SANITARIA
Birkmeyer NJA, Dimick JB, Share D, Hawasli A, English WJ, Genaw J et al for the Michigan Bariatric Surgery Collaborative. Hospital Complication Rates With Bariatric Surgery in Michigan. JAMA 2010; 304: 435-442. R TC PDF
Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH et al on behalf of the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing. Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults: A Scientific Statement From the American Heart Association. Circulation 2010; 122: 406-441. R TC PDF
PREVENCIÓN DEL CÁNCER
The FUTURE I/II Study Group. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010; 341: 3493-. R TC PDF
McPherson K. Screening for breast cancer—balancing the debate. BMJ 2010; 341: 3106-. R TC PDF
Longo DL. New Therapies for Castration-Resistant Prostate Cancer. N Engl J Med 2010; 363: 479-481. R TC PDF
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF et al for the IMPACT Study Investigators. Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer. N Engl J Med 2010; 363: 411-422. R TC PDF
Reeves GK, Travis RC, Green J, Bull D, Tipper S, Baker K et al for the Million Women Study Collaborators. Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci. JAMA 2010; 304: 426-434. R TC PDF
Neugut; AI, Lebwohl B. Colonoscopy vs Sigmoidoscopy Screening: Getting It Right. JAMA 2010; 304: 461-462. R TC PDF
Shao YH, Albertsen PC, Roberts CB, Lin Y, Mehta AR, Stein MN et al. Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL. Arch Intern Med 2010; 170: 1256-1261. R TC PDF
Hoffman RM, Zeliadt SB. The Cautionary Tale of PSA Testing: Comment on ´Risk Profiles and Treatment Patterns Among Men Diagnosed as Having Prostate Cancer and a Prostate-Specific Antigen Level Below 4.0 ng/mL´. Arch Intern Med 2010; 170: 1262-1263. R TC PDF
PREVENCIÓN EN EL ANCIANO
Young J, Murthy L, Westby M, Akunne A, O Mahony R on behalf of the Guideline Development Group. Guidelines: Diagnosis, prevention, and management of delirium: summary of NICE guidance. BMJ 2010; 341: 3704-. R TC PDF
Witlox J, Eurelings LSM, de Jonghe JFM. Kalisvaart KJ, Eikelenboom P. van Gool WA. Delirium in Elderly Patients and the Risk of Postdischarge Mortality, Institutionalization, and Dementia: A Meta-analysis. JAMA 2010; 304: 443-451. R TC PDF
PREVENCIÓN EN LA INFANCIA Y LA ADOLESCENCIA
The Consortium on Safe Labor. Respiratory Morbidity in Late Preterm Births. JAMA 2010; 304: 419-425. R TC PDF
PREVENCIÓN EN LA MUJER
Nelson HD, Haney EM, Dana T, Bougatsos Ch, Chou R. Screening for Osteoporosis: An Update for the U.S. Preventive Services Task Force. Ann Intern Med 2010; 153: 99-111. R TC PDF
Gerdes AM, Iervasi G. Thyroid Replacement Therapy and Heart Failure. Circulation 2010; 122: 385-393. R TC PDF
PREVENCIÓN DE LAS ENFERMEDADES INFECCIOSAS
The FUTURE I/II Study Group. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ 2010; 341: 3493-. R TC PDF
W.C. Koff, S.F. Berkley. The Renaissance in HIV Vaccine Development — Future Directions. N Engl J Med 2010; 363: 7-. R TC PDF
Horton R, Das P. Rescuing people with HIV who use drugs. Lancet 2010; 376: 207-208. R TC PDF
Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV/AIDS and people who use drugs. Lancet 2010; 376: 208-211. R TC PDF
Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet 2010; 376: 268-284. R TC PDF
Lang S, Mary-Krause M, Cotte L. Gilquin J, Partisani M, Simon A et al. Impact of Individual Antiretroviral Drugs on the Risk of Myocardial Infarction in Human Immunodeficiency Virus–Infected Patients: A Case-Control Study Nested Within the French Hospital Database on HIV ANRS Cohort CO4. Arch Intern Med 2010; 170: 1228-1238. R TC PDF
Gordon J, Quinn CP, Shadomy S, Messonnier N. Use of Anthrax Vaccine in the United Sta tes: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Rec Rep 2010; 59: 1-30. R TC PDF

 

 
 


© 2004 PAPPS
Portaferrissa, 8 pral. 08002 Barcelona
Tel.: 93 317 03 33 / Fax: 93 317 77 72
papps@semfyc.es